Autoimmune Bullous Skin Diseases
Autoimmune Bullous Skin Diseases is a research topic within Pathology and Forensic Medicine. Science Explorer counts 30k research works in it since 1950. 9.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathogenesis, diagnosis, and treatment of pemphigoid diseases, particularly bullous pemphigoid and pemphigus vulgaris. It covers topics such as autoantibodies, rituximab therapy, epidemiology, and the use of immunosuppressive therapy including intravenous immunoglobulin. The research also delves into the role of desmoglein in disease pathology and autoimmune mechanisms.
- Pemphigoid
- Autoantibodies
- Rituximab
- Bullous Pemphigoid
- Desmoglein
- Autoimmune
- Immunosuppressive Therapy
- Diagnosis
- Epidemiology
- Intravenous Immunoglobulin
- Research works
- 30k fractional, since 1950
- In the world top 10%
- 2.9k per year above
- Top-10% rate
- 9.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +36% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autoimmune Bullous Skin Diseases research?
By volume, the United States and India publish the most (1.2k and 483 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.2k works
- 2 India 483 works
- 3 China 467 works
- 4 Japan 274 works
- 5 Germany 257 works
- 6 France 233 works
- 7 Spain 217 works
- 8 United Kingdom 208 works
- 9 Italy 204 works
- 10 Brazil 135 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autoimmune Bullous Skin Diseases research?
By volume in 2022–2025, University of Lübeck publishes the most Autoimmune Bullous Skin Diseases research, followed by Post Graduate Institute of Medical Education and Research and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 University of LübeckGermany 28 works
- 2 Post Graduate Institute of Medical Education and ResearchIndia 26 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 26 works
- 4 University of MiamiUnited States 18 works
- 5 Tehran University of Medical SciencesIran 18 works
- 6 Icahn School of Medicine at Mount SinaiUnited States 17 works
- 7 Harvard UniversityUnited States 16 works
- 8 Medical University of WarsawPoland 16 works
- 9 All India Institute of Medical SciencesIndia 16 works
- 10 Yale UniversityUnited States 15 works
Who are the leading researchers in Autoimmune Bullous Skin Diseases?
The most-cited researchers publishing on Autoimmune Bullous Skin Diseases include Winfried März, Luigi Naldi and Roderick J. Hay.
- 1 Winfried März Germany 5.2k citations
- 2 Luigi Naldi Italy 4.7k citations
- 3 Roderick J. Hay United Kingdom 4k citations
- 4 Zena Werb United States 3.3k citations
- 5 Thomas Schwarz United States 3.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autoimmune Bullous Skin Diseases research done?
The largest centres of Autoimmune Bullous Skin Diseases research in 2022–2025 are Beijing (China), Paris (France), New York (United States) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Lübeck.
Largest cities, 2022–2025
Where it is the local speciality
- LübeckDE · 32.0 works35×
Location quotient: how much more of its research is in Autoimmune Bullous Skin Diseases than the world average.
Where is the best place to study Autoimmune Bullous Skin Diseases?
Among universities, judged by research, University of Lübeck, Philipps University of Marburg and University of Miami score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of LübeckGermany | 77.1 | 19.6% | 36.0× | 28 | +61.9% |
| 2 | Philipps University of MarburgGermany | 57.6 | 17.9% | 9.1× | 12 | +71.9% |
| 3 | University of MiamiUnited States | 56.2 | 16.9% | 7.1× | 18 | +37.2% |
| 4 | Post Graduate Institute of Medical Education and ResearchIndia | 54.6 | 6.2% | 15.0× | 26 | +15.3% |
| 5 | Poznan University of Medical SciencesPoland | 53.9 | 14.7% | 11.5× | 10 | +82.0% |
| 6 | Tehran University of Medical SciencesIran | 53.6 | 11.2% | 7.3× | 18 | +87.6% |
| 7 | Medical University of WarsawPoland | 53.5 | 6.1% | 13.8× | 16 | +101.0% |
| 8 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 51.4 | 16.0% | 5.0× | 26 | -7.4% |
| 9 | Oregon Health & Science UniversityUnited States | 51.4 | 21.0% | 5.3× | 8 | +164.1% |
| 10 | Icahn School of Medicine at Mount SinaiUnited States | 50.4 | 12.5% | 6.8× | 17 | +46.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Autoimmune Bullous Skin Diseases research growing?
Output in 2018–2022 was 36% higher than in 2013–2017, peaking in 2023. The fastest-growing topics are Autoimmune Bullous Skin Diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.